The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 
Chemical Compound Review

ACMC-1BYNA     1-chloro-2-isocyanato-ethane

Synonyms: AG-A-41511, AG-E-42112, ANW-23647, NSC-87418, NSC87418, ...
 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

Disease relevance of Chloroethylisocyanate

 

High impact information on Chloroethylisocyanate

 

Chemical compound and disease context of Chloroethylisocyanate

  • In contrast to the insensitivity of hepatomas to dietary modulation of nucleotide levels, treatment of hepatoma-bearing rats with carbamoylating agents (sodium cyanate and 2-chloroethyl isocyanate) caused decreases in the levels of nucleotides in the tumors which were generally greater than in host livers [7].
 

Biological context of Chloroethylisocyanate

 

Associations of Chloroethylisocyanate with other chemical compounds

 

Gene context of Chloroethylisocyanate

References

  1. Action of carbamoylating agents on the uptake of metabolites in hepatomas and liver. Lea, M.A., Luke, A., Hu, J.J., Velazquez, O. Biochem. Pharmacol. (1987) [Pubmed]
  2. Antimitotic agents. Chiral isomers of ethyl [5-amino-1,2-dihydro-3-(4-hydroxyphenyl)-2-methylpyrido[3,4-b]pyrazin-7 -yl]carbamate. Temple, C., Rener, G.A. J. Med. Chem. (1992) [Pubmed]
  3. Differential inhibition of cellular glutathione reductase activity by isocyanates generated from the antitumor prodrugs Cloretazine and BCNU. Rice, K.P., Penketh, P.G., Shyam, K., Sartorelli, A.C. Biochem. Pharmacol. (2005) [Pubmed]
  4. Glutathione and N-acetylcysteine conjugates of 2-chloroethyl isocyanate. Identification as metabolites of N,N'-bis(2-chloroethyl)-N-nitrosourea in the rat and inhibitory properties toward glutathione reductase in vitro. Davis, M.R., Kassahun, K., Jochheim, C.M., Brandt, K.M., Baillie, T.A. Chem. Res. Toxicol. (1993) [Pubmed]
  5. Mechanism of action of 2-haloethylnitrosoureas on deoxyribonucleic acid. Pathways of aqueous decomposition and pharmacological characteristics of new anticancer disulfide-linked nitrosoureas. Lown, J.W., Koganty, R.R., Tew, K.D., Oiry, J., Imbach, J.L. Biochem. Pharmacol. (1985) [Pubmed]
  6. Inhibition of protein A24 lyase by nitrosoureas. Markussen, G., Smith-Kielland, I., Dornish, J.M. FEBS Lett. (1984) [Pubmed]
  7. Selective modulation of nucleotide levels in rat liver and hepatomas by high-orotate or arginine-deficient diets and by carbamoylating agents. Lea, M.A., Luke, A., Oliphant, V. Biochim. Biophys. Acta (1988) [Pubmed]
  8. Performance of 181 chemicals in a Drosophila assay predominantly monitoring interchromosomal mitotic recombination. Vogel, E.W., Nivard, M.J. Mutagenesis (1993) [Pubmed]
  9. Antitumour imidazotetrazines--IV. An investigation into the mechanism of antitumour activity of a novel and potent antitumour agent, mitozolomide (CCRG 81010, M & B 39565; NSC 353451). Horgan, C.M., Tisdale, M.J. Biochem. Pharmacol. (1984) [Pubmed]
  10. Anomeric O-acylation of Kdo using alkyl and aryl isocyanates. Ichiyanagi, T., Yamasaki, R. Carbohydr. Res. (2005) [Pubmed]
 
WikiGenes - Universities